Enanta Pharmaceuticals, Inc.ENTANASDAQ
LOADING
|||
Debt to Equity Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Debt-to-equity ratio
Latest
3.11
↑ 417% above average
Average (9y)
0.60
Historical baseline
Range
High:3.11
Low:0.00
CAGR
+126.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | 3.11 | +77.0% |
| 2024 | 1.75 | +71.0% |
| 2023 | 1.03 | +1135.8% |
| 2022 | 0.08 | +385.3% |
| 2021 | 0.02 | -18.6% |
| 2020 | 0.02 | +4761.7% |
| 2019 | 0.00 | -41.9% |
| 2018 | 0.00 | -51.0% |
| 2017 | 0.00 | -22.8% |
| 2016 | 0.00 | - |